OBJECTIVE: The rate of glucose disposal was determined in 10 black and 10 white obese nondiabetic urban women from South Africa to assess insulin resistance. DESIGN AND METHODS: Euglycemic hyperinsulinemic clamp and body composition analysis. RESULTS: Age, body mass index (BMI), anthropometric measurements and body composition were similar in both groups of women. A ®ve-level computed tomography (CT) scan showed a similar mean subcutaneous fat mass in both groups of women (black obese women 555 AE 9.0 vs white obese women 532 AE 6.0 cm 2 ), but less visceral fat in black obese women (90 AE 3.0 vs 121 AE 3.1 cm 2 ; P`0.05). Black obese women had higher fasting free fatty acid (997 AE 69 vs 678 AE 93 m mmolal; P`0.05) and lactate concentrations (1462 AE 94 vs 1038 AE 39 m mmolal; P`0.05), but lower fasting insulin levels (87 AE 12 vs 155 AE 9 pmolal; P`0.001). Black obese women also had a more favorable HDL: total cholesterol ratio (30.5% vs 23.0%; P`0.04). The mean glucose disposal rate (M) and disposal expressed as glucose sensitivity index (MaI) were reduced in the black obese women vs white obese women (M: 7.1 AE 0.8 vs 13.7 AE 1.0 mmolakg Á min À1 Â100; P`0.01, and MaI: 0.12 AE 0.01 vs 0.24 AE 0.02 mmolakg Á min À1 apmolal Â1000; P`0.01). Only black obese women showed a signi®cant decrease in C-peptide levels during the clamp (2.9 AE 0.22 vs 1.2 AE 0.12 nmolal; P`0.001). During the euglycemic period, the black obese women had higher lactate levels at all time points, but only the white obese women had increased lactate levels (918 AE 66 to 1300 AE 53 m mmolal; P`0.05). CONCLUSION: Black obese women demonstrate a higher degree of insulin resistance, despite less visceral fat and a higher HDL: total-cholesterol ratio. In addition, endogenous b b-cell secretory function in black obese women appears to be more sensitive to the suppressive effect of exogenous insulin administration. The signi®cant increase in lactate levels in white obese women con®rms that they are more insulin sensitive.
Introduction
The prevalence of obesity (body mass index (BMI) b 30 kgam 2 ) is on the order of 55% for urban South African black women (BW) between the ages of 45 and 65 y. 1, 2 Moreover, the urban obese BW, who are as Westernized in diet and lifestyle as the white women (WW), more commonly present with hypertension (30% vs 15%) 2 and non-insulin-dependent diabetes mellitus (7% vs 3.6%). 3, 4 The lower incidence 5 and mortality from ischemic heart disease in the BW (8a100,000 compared with 55a100,000 in the WW), 6 may be partly caused by a more favorable lipid pro®le, 7, 8 but could also be related to other factors that have not yet been identi®ed. Our group has recently shown that obesity in our BW is not as benign 9 as has previously been suggested. 10, 11 We have demonstrated a higher degree of in vitro adipose tissue insulin resistance in the BW compared with the WW (data in press). 12 In addition, the BW have a brisker in vivo adipose tissue lipolysis. 9, 13 The resulting high postabsorptive free fatty acid (FFA) levels, 9, 13 together with the relative insulinopenia of the black Southern African people, 9,14 ± 16 may therefore also have been instrumental in creating in vivo insulin resistance, 17, 18 to glucose disposal in muscle tissue.
In contrast to insulin and proinsulin, C-peptide does not appear to be metabolically active. 19, 20 It is considered to be a good marker of insulin secretion because of its equimolar secretion with insulin, negligible hepatic extraction and constant peripheral clearance. 21, 22 Because of its long plasma half-life it will most accurately re¯ect insulin secretion rates during steady state conditions. 23, 24 The objective of this research study was therefore to assess in vivo glucose disposal in muscle in these ethnic groups, as well as to measure C-peptide and lactate concentrations (as an additional measure of insulin resistance) during euglycemic conditions by using the euglycemic hyperinsulinemic clamp. In addition we assessed body composition and the degree of visceral adiposity.
Research design and methods
Ten black and 10 white obese women were matched for the clinical and anthropometric features as listed in Table 1 , as well as for diet, duration of obesity (less than 5 y), level of physical and habitual activity, number of offspring (no more than three) and socioeconomic background. None of the women were postmenopausal or on oral contraceptives. The women were studied within the ®rst 10 days of the onset of the follicular phase of their menstrual cycle. The exclusion criteria included diabetes and diseases of the major organs, as well as excessive smoking or alcohol consumption. No vigorous exercise was allowed for 12 h before the test date. The investigations were started at 7:00 h, after an overnight fast of 9 h, and the tests were conducted during the luteal phase of the menstrual cycles. All the patients gave informed consent, and the study was approved by the committee for research on human subjects of the University of the Witwatersrand.
Biochemical analyses
Glucose was measured using an enzymatic colorimetric method (GOD-PAP, Boehringer Mannheim, Mannheim, Germany), insulin levels using an enzyme-ampli®ed sensitivity immunoassay (EASIA, Medgenix Diagnostics, Fleurus, Belgium; normal range 13.8 ± 172 pmolal), and C-peptide levels with a radioimmunoassay kit (Medgenix Diagnostics, Fleurus Belgium; normal range 110 ± 1270 pmolal). FFA levels were measured using the half-micro test (Boehringer Mannheim). Plasma lactate was analyzed within 14 days, according to a¯uorometric method described by Loomis. 25 The specimens were centrifuged within the hour, and the serum was stored at À70 C until analyzed in a single batch to avoid interassay variation. The fasting lipogram was analyzed with enzymatic colorimetric tests (CHOD-PAP and GPO-PAP, Boehringer Mannheim, Mannheim, Germany).
Body composition analyses
This was performed after a 10 ± 12 h overnight fast with bioelectrical impedance analysis. 13 The Bodystat machine (Bodytrach Pty Ltd, Stellenbosch, South Africa) was used to assess the body composition for fat and muscle tissue (kg; %). The bioimpedance equations are based on the South African population as a whole:
where H height), wt body mass, z whole body impedance, and a, b, c, d and e are regression coef®cients, validated by the Dunn Nutrition Center, University of Cambridge, Cambridge, UK.
CT scan measurements
In the week prior to their investigation a ®ve-level CT scan was done (Philips SR 7000, The Netherlands) as previously described. 12 The women were in a fasted state. The scanning criteria were: (1) 10 mm slice thickness; (2) 120 kV; (3) 250 mA; (4) 2 s; and (5) 340 ± 480 mm ®eld of view (FOV), depending on the size of the subject. Photographic images were taken in resting expiration. The ®ve levels were derived from two scanograms and included a CT scan slice at the level of the diaphragm, the umbilicus, L4 ± 5 lumbar disc, the widest diameter of the pelvis and mid-thigh (the total distance from the iliac crest to acetabulae and from acetabulae to the knee joint, divided by two). The ®rst scanogram included the diaphragm, the umbilicus (marked with a metallic coin), iliac crest and symphysis pubis, with a maximum length of 500 mm from the umbilicus. The second scanogram extended from the symphysis pubis to the knees. The parasagittal diameter was measured at the level of L4 ± 5. The fat areas were calculated with a region of interest seeding programme on a Philips Gyroview workstation (fat values were chosen between À30 and À130 HU (Houns®eld units)). The areas of the subcutaneous and visceral fat were calculated separately and the anatomical boundaries were as described by Kvist et al. 26, 27 Visceral fat was measured at the top three levels.
Euglycemic clamp studies
The patients were studied in the supine position. Two polyethylene catheters were inserted intravenously, one in each forearm. One catheter was used for infusion of insulin (Actrapid, Novo Nordisk, Copenhagen, Denmark) and 20% glucose. The contralateral arm was placed under a heating pad, which ensured the sampling of arterialized venous blood. 28 Each study started with a primed infusion of insulin for 10 min, followed by a constant infusion rate of 80 mUam 2 min for 120 min. Potassium chloride (0.1 M) was infused at a rate of 10 mmolah to prevent hypokalemia. The exogenous 20% glucose infusion rate varied accordingly at 10 min intervals as Insulin resistance in black women M-T van der Merwe et al calculated from a computerized algorithm based on a minimal model of glucose kinetics. 29 ± 31 Blood glucose levels were targeted at a concentration of 5.5 mmolal and clamped at these levels for 60 min. Fasting blood samples were taken for plasma glucose, insulin, C-peptide, FFA and lactate, and repeated at 20 min intervals throughout the euglycemic period of the clamp study.
Statistical analyses
Data are expressed as meanAE s.e.m. Signi®cance for multiple samples was established by one-way ANOVA. Statistical signi®cance of parametric data was assessed by Student's paired and unpaired t-test. Results were deemed signi®cant at P`0.05.
Results

Clinical features
The clinical characteristics and body composition measurements are shown in Table 1 . The women were well matched for age, BMI, surface area and waist-to-hip ratio (WHR). Analyses of body composition showed no difference between the two groups of women apart from the amount of visceral fat mass, which was signi®cantly less in the black women.
Fasting biochemical measurements
There was no difference in the fasting plasma glucose or glycerol levels between the two groups of women. (Table 2 ). However, the group of BW started off with lower plasma insulin levels (87AE 12 vs 155AE 9 pmolal; P`0.001, Table 2 ), but higher plasma FFA levels (997AE 69 vs 678 AE 93 mmolal; P`0.05) as well as higher plasma lactate levels (1462AE 94 vs 1038AE 39 mmolal; P`0.05) ( Figure  2) . The WW had a higher total cholesterol level and a less favorable HDL: total cholesterol ratio (23 AE 1.2% vs 30.5 AE 3.0%; P`0.04; Table 4 ).
Biochemical measurements during the euglycemic hyperinsulinemic clamp
During the 60 min euglycemic period, equivalent mean plasma glucose and insulin concentrations were achieved, in the black and white groups of women. (Table 2) The mean insulin concentrations ranged between 483AE 46 and 807AE 64 pmolal in the two groups and was not found to differ signi®cantly. This concentration is suf®cient to suppress both endogenous hepatic gluconeogenesis and pancreatic (prehepatic) insulin secretion. 28 ± 30 During the euglycemic period of the clamp, as the rate of lipolysis diminished, the FFA and glycerol concentrations decreased signi®cantly in both groups of women (ANOVA, P`0.001 and P`0.01). At 2 h, no signi®cant difference could be documented in these concentrations between the two groups of women (Table 2) . We found a signi®cant difference in the glucose disposal rates between the BW (7.1AE 0.8 mmolakg Á min À1 Â 100) and the WW (13.7 AE 1.0 mmolakg Á min À1 Â100 P`0.01); (Table 3 ). The mean glucose disposal rate corrected for the mean prevailing insulin level during steady state (MaI), was likewise reduced in the black group of women (0.12 AE 0.01 vs 0.24 AE 0.02 mola kg Á min À1 apmolal Â1000; P`0.01). The C-peptide concentrations remained signi®-cantly lower in the BW throughout the euglycemic period ( Figure 1 ). In addition, the C-peptide levels decreased signi®cantly in the BW only (fasting, 2.9 AE 0.22 vs 120 min, 1.2 AE 0.12 nmolal; P`0.001; Figure 1 ). This accounted for an overall decrease of 57% in the C-peptide levels of the BW. By contrast, the WW showed only a 9.8% decrease in C-peptide levels (fasting, 5.0 AE 0.4 vs 120 min, 4.6 AE 0.4 nmolal; P NS, Figure 1 ). 
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The plasma lactate levels increased steadily and signi®cantly only in the WW during euglycemia (60 min: 918 AE 66 vs 120 min: 1300 AE 53 mmolal; P`0.05, Figure 2 ). In the BW there was a small increase in plasma lactate levels at 80 min, but this was insigni®cant (60 min: 1462 AE 94 vs 120 min: 1387 AE 110 mmolal; P NS). In addition, the plasma lactate levels were higher in the BW at all time points compared with the WW (Figure 2 ).
Discussion
Obesity is associated with the development of the most prevalent diseases of modern society. It can therefore no longer be viewed just as a health risk Ð it needs to be investigated as a disease in its own right. In South Africa, obesity amongst the urban black women has often been described as`benign' because of its lack of associated ischemic heart disease. 5,6,10 However, the incidence of hypertension and diabetes amongst these women are highly prevalent. 2, 4, 32 It therefore seemed logical to investigate two closely matched groups of obese women from different ethnic backgrounds, but of similar socioeconomic status, with hyperinsulinemic euglycemic clamp studies, in order to determine their degree of insulin resistance. Recent results published by our own group indicated a signi®cant degree of in vivo 9, 14 and in vitro 12 adipose tissue insulin resistance in the black people. The pathophysiology leading to insulin resistance in the black obese women is intriguing and the sequence of events somewhat different to that previously described in other Westernized societies. The relative insulinopenic state of the black Southern African people 9,13 ± 16 appears to be instrumental in causing their higher degree of adipose tissue lipolysis. 9, 14 This lack of the antilipolytic effect of insulin, together with higher adipose tissue blood ow rates 9,14 has led to an increase in the release of glycerol per unit of adipose tissue. 9, 14 The higher postabsorptive FFA levels documented in the black women as a result of their more rapid lipolysis 9 could have a two-fold effect on their intermediary metabolism. Elevated FFA levels may induce insulin resistance in both muscle and liver 33 and will diminish insulin-mediated glucose disposal into peripheral tissue. 34, 35 One possible method is by increasing thē ux of fructose 6-phosphate into the hexosamine pathways with a resultant defect in insulin signaling by phosphoinositide-3 kinase. 36, 37 In addition, chronically elevated FFA levels will cause an additional longitudinal impairment of b-cell function in humans. 38, 39 Data from the present study indicated a higher degree of insulin resistance to muscle glucose disposal in the black obese women compared with the white obese women (M), even when corrected for the prevailing insulin level (MaI). Several previous studies have indicated that an enhanced lipid oxidation rate in obese subjects will be associated with a decreased glucose oxidation rate. 40, 41 In addition, nonoxidative routes of glucose utilization will be increased in the post-absorptive state in obesity. 42 These routes include glucose storage as glycogen, anaerobic glycolysis leading to lactate production and lipogenesis. 43 The conversion of glucose to lactate can occur in several tissues, such as skeletal muscle, heart and adipose tissue. 44, 45 In skeletal muscle, lactate production could be the consequence of privileged lipid oxidation, or the inhibition of pyruvate dehydrogenase by acetyl-CoA and the resultant decrease of pyruvate oxidation. 46 We have previously documented a higher (post-absorptive) adipose tissue lactate production in the obese black women, compared with the white obese women. 9 In the present study we documented a higher post-absorptive plasma lactate level, as well as a greater degree of insulin resistance in the black obese women. Both Lovejoy et al and Yki-Ja Èrvinen et al previously suggested that elevated post-absorptive lactate levels could result from resistance to insulin Figure 1 Plasma C-peptide levels in black and white obese women at fasting and during the hyperinsulinemic euglycemic clamp. Data in means AE s.e.m. P unpaired student's t-test; *P`0.05; **P`0.001; {ANOVA, P`0.001. Figure 2 Plasma lactate levels in black and white obese women at fasting and during the hyperinsulinemic euglycemic clamp. Data in means AE s.e.m. P unpaired student's t-test; *P`0.05; **P`0.01; {ANOVA, P`0.05.
Insulin resistance in black women M-T van der Merwe et al inhibition of overnight glycogenolysis, 47 ± 49 with the lactate concentration determined by the rate of glucose disposal in extramuscular tissues rather than by the ambient glucose or insulin concentrations per se. 48, 49 Lovejoy et al also found that the ability to produce lactate accurately in response to a glucose and insulin challange is reduced with progressively increased insulin resistance. 47 It would therefore appear as if our black obese women, under the in¯uence of a greater degree of insulin resistance, will convert more glucose to lactate in the fasted state, using mainly nonoxidative pathways in extramuscular tissue, but will have a diminished lactate appearance following intravenous glucose and insulin.
In South Africa, black patients with type 2 diabetes frequently present with ketoacidosis (Flatbush diabetes). 50, 51 The majority of patients demonstrate progressive b-cell failure. This is in keeping with the concept that black Southern Africans either inherit or acquire a decreased pancreatic beta cell mass, 52 and that the functional ability of these b-cells will become rapidly exhausted when glucose intolerance supervenes, with many of the patients requiring insulin therapy to initially restore normoglycemia. 50 Furthermore, in South Africa, newly diagnosed type 2 black diabetics treated with sulphonylurea therapy demonstrated an increase in insulin receptor concentration, but showed no changes in basal insulin secretion. 53 In the present study, endogenous b-cell secretory function in the black women appears to be more sensitive to the suppressive effect of exogenous insulin administration. The mechanism by which insulin turns off its own secretion is not clear, but appears to be neurally mediated. 54 Even though the precise mechanism is still debated, the phenomenon appears to exist. 55 ± 57 Furthermore it would appear as if in vivo insulin clearance is impaired in patients with target cell resistance to insulin. 58 The ®nding of both lower fasting insulin levels as well as exaggerated suppression of C-peptide by insulin in the black obese women therefore suggests defective b-cell function, as Cpeptide kinetics are expected to remain unchanged in both nonobese and obese subjects during the euglycemic hyperinsulinemic clamp. 59 It therefore becomes an interesting if not debatable question as to what we should use to treat type 2 diabetes in the black population, so as to both best stimulate and preserve their rapidly declining low b-cell mass. One could argue that they warrant treatment with either an insulin sensitizer, or a drug that could effectively lower their FFA concentration in the long term. Finally, we have again con®rmed a smaller amount of visceral fat mass in the black obese women. 9, 13 In conclusion, the obese black women have a higher degree of acquired insulin resistance, despite less visceral fat. This is in keeping with the work performed by Lovejoy et al, who also showed that black women from the USA are more insulin resistant, despite a lower amount of visceral fat. The rapidly rising incidence of obesity in black women in South Africa has major health implications as it appears that obesity is less`benign' in the black women than previously suspected. Apart from their more favorable lipid pro®le, however, there may be other factors protecting them from an escalating incidence of ischemic heart disease. 61 
